Viewing Study NCT03440450


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2025-12-30 @ 8:21 AM
Study NCT ID: NCT03440450
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-18
First Post: 2018-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer
Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module